ConductScience.org, home

Paper37573009

Consideration of vendor-related differences in hepatic metabolic stability data to optimize early ADME screening in drug discovery.

Shah P and 5 others. SLAS Discov, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Consideration of vendor-related differences in hepatic metabolic stability data to optimize early ADME screening in drug discovery. Papers, record 37573009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37573009

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Consideration of vendor-related differences in hepatic metabolic stability data to optimize early ADME screening in drug discovery.
PubMed
Journal
SLAS Discov
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.69, provisional
iCite
Revised in PubMed
2025-07-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shah PPranav
2Padilha ECElias C
3Kato RRintaro
4Siramshetty VBVishal B
5Huang WWenwei
6Xu XXin

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LiverMajor topic
Drug DiscoveryMajor topic
Rats
Animals
Microsomes, Liver
Biological Availability
Drug Evaluation, Preclinical

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
Z99 TR999999Intramural NIH HHSUnited StatesZ99TR999999PubMedNIH RePORTER
ZIATR000369NIHNIH RePORTER

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114567798Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates.J Biomol Screen2003https://conductscience.org/library/papers/14567798PubMed
215230342Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?Eur J Drug Metab Pharmacokinet2004https://conductscience.org/library/papers/15230342PubMed
334176369Validating ADME QSAR Models Using Marketed Drugs.SLAS Discov2021https://conductscience.org/library/papers/34176369PubMed
423333322Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.Pharmacol Ther2013https://conductscience.org/library/papers/23333322PubMed
533992989NOX2 inhibitor GSK2795039 metabolite identification towards drug optimization.J Pharm Biomed Anal2021https://conductscience.org/library/papers/33992989PubMed
616790553Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes.Drug Metab Dispos2006https://conductscience.org/library/papers/16790553PubMed
710836130High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery.Annu Rev Pharmacol Toxicol2000https://conductscience.org/library/papers/10836130PubMed
818220563The conduct of drug metabolism studies considered good practice (II): in vitro experiments.Curr Drug Metab2007https://conductscience.org/library/papers/18220563PubMed
934183376Development of Robust Quantitative Structure-Activity Relationship Models for CYP2C9, CYP2D6, and CYP3A4 Catalysis and Inhibition.Drug Metab Dispos2021https://conductscience.org/library/papers/34183376PubMed
1033431020Predicting liver cytosol stability of small molecules.J Cheminform2020https://conductscience.org/library/papers/33431020PubMed
1132125203In vitro-in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization.Xenobiotica2020https://conductscience.org/library/papers/32125203PubMed
1231898492An in vitro toolbox to accelerate anti-malarial drug discovery and development.Malar J2020https://conductscience.org/library/papers/31898492PubMed
1312612645ADMET in silico modelling: towards prediction paradise?Nat Rev Drug Discov2003https://conductscience.org/library/papers/12612645PubMed
1433244000Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.Sci Rep2020https://conductscience.org/library/papers/33244000PubMed
1527417180An Automated High-Throughput Metabolic Stability Assay Using an Integrated High-Resolution Accurate Mass Method and Automated Data Analysis Software.Drug Metab Dispos2016https://conductscience.org/library/papers/27417180PubMed
1635350742Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development.ADMET DMPK2019https://conductscience.org/library/papers/35350742PubMed
1735435491Identification of environmental chemicals that activate p53 signaling after in vitro metabolic activation.Arch Toxicol2022https://conductscience.org/library/papers/35435491PubMed
1827636111In Vitro Drug Metabolism Using Liver Microsomes.Curr Protoc Pharmacol2016https://conductscience.org/library/papers/27636111PubMed
1911727321The prediction of human clearance from hepatic microsomal metabolism data.Curr Opin Drug Discov Devel2001https://conductscience.org/library/papers/11727321PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42562981The Enzyme-Bag Platform for Cytochrome P450 Biotransformation and High-Throughput Drug Metabolism Screening.Methods Mol Biol2026https://conductscience.org/library/papers/42562981PubMed
42137024Assessing the impact of data harmonization on human liver microsomal stability prediction model performance.Results Chem2026https://conductscience.org/library/papers/42137024PubMed
41530259Comparative analysis of sex-based, vendor-based, and species differences in cytochrome P450 metabolism.Sci Rep2026https://conductscience.org/library/papers/41530259PubMed
41503944In Vitro Pharmacokinetic Profiling of Thiourea Derivatives of Naproxen With Anti-Inflammatory and Anticancer Activity.Chem Biodivers2026https://conductscience.org/library/papers/41503944PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP2C91559PubTator's text mininghttps://conductscience.org/library/genes/1559NCBI Gene
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37573009

GET https://conductscience.org/api/papers/v1/37573009/authors